trial

Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression

NCTId NCT05480826
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 50 (estimated)
Sponsored by Fondation FondaMental
Primary completion 2027-09-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
Single
Start
2023-03-15
Primary completion
2027-09-15
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
study of the transmission of genetic variants

Sponsors

Fondation FondaMentalLead Sponsor

Investigators

2
Marion Leboyer, MD PhDStudy Chair
Stephane JAMAIN, PhDStudy Director

Sites

1 total
Créteil, France

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2027-09-15
Status
RECRUITING
relationships
The graph out of here
drug
study of the transmission of genetic variants
drug
lead_sponsor
Fondation FondaMental
company
indication
Psychiatric Disorder
indication
Mental Disorders
indication
investigator
Marion Leboyer, MD PhD
person
Stephane JAMAIN, PhD
person